About CellAegis Devices
CellAegis Devices is a company based in Mississauga (Canada) founded in 2009. CellAegis Devices has raised $19.13 million across 6 funding rounds from investors including CTI Life Sciences, MaRS Catalyst Fund and Broadview Ventures. CellAegis Devices operates in a competitive market with competitors including Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical, among others.
- Headquarter Mississauga, Canada
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Jurisdiction Bangalore North, Karnataka, India
-
Annual Revenue
$403.09 K (USD)19.31as on Mar 31, 2022
-
Net Profit
$26.11 K (USD)-14.87as on Mar 31, 2022
-
EBITDA
$31.2 K (USD)28.43as on Mar 31, 2022
-
Total Equity Funding
$19.13 M (USD)
in 6 rounds
-
Latest Funding Round
$9.5 M (USD), Series C
Mar 14, 2017
-
Investors
CTI Life Sciences
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CellAegis Devices
CellAegis Devices has successfully raised a total of $19.13M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $9.5 million completed in March 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CellAegis Devices
CellAegis Devices has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include CTI Life Sciences, MaRS Catalyst Fund and Broadview Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are made in life sciences companies.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Seed-stage life sciences investments are made in the US.
|
Locked | Locked | Locked |
Investor details for CellAegis Devices
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CellAegis Devices
Investment portfolio details for CellAegis Devices
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CellAegis Devices
Detailed financials for CellAegis Devices
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cellaegis Devices Comparisons
Peer comparison for CellAegis Devices
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CellAegis Devices
CellAegis Devices operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Devices for treating peripheral and coronary vascular disease are developed.
|
|
| Locked | Locked | Locked |
Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature
|
|
| Locked | Locked | Locked |
Scoring balloon catheters for coronary and peripheral angioplasty are developed.
|
|
| Locked | Locked | Locked |
Smart devices for monitoring coronary artery disease are developed.
|
|
| Locked | Locked | Locked |
Embolization devices are developed using Shape Memory Polymer foams.
|
|
| Locked | Locked | Locked |
Developer a system for venous arterialization of the lower limbs
|
Detailed competitors of CellAegis Devices
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cellaegis Devices
Complete news archive for CellAegis Devices
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CellAegis Devices
CellAegis Devices was founded in 2009 and raised its 1st funding round 4 years after it was founded.
CellAegis Devices is headquartered in Mississauga, Canada. It is registered at Mississauga, Ontario, Canada.
CellAegis Devices is a funded company, having raised a total of $19.13M across 6 funding rounds to date.
Annual revenue of CellAegis Devices is $403.09K as on Mar 31, 2022.
CellAegis Devices was founded in 2009 in Mississauga, Canada, within the medical devices sector focused on cardiology. The autoRIC device is being developed as a portable tool for delivering chronic remote ischemic conditioning to patients post-acute myocardial infarction or during cardiothoracic procedures. Point-of-care application is enabled for adults over 18. CE Mark and Health Canada approvals have been obtained, while investigational status is held in the US as of 2018.
CellAegis Devices's top competitors include Contego Medical, Limflow and Shape Memory Medical.
CellAegis Devices has 3 investors. Key investors include CTI Life Sciences, MaRS Catalyst Fund, and Broadview Ventures.